ANTI-RNP AND ANTI-SM ANTIBODY TEST— 510(k) K895338
Substantially EquivalentImmco Diagnostics, Inc.
FDA 510(k) clearance K895338 for ANTI-RNP AND ANTI-SM ANTIBODY TEST, Substantially Equivalent on 1989-10-17. Applicant: Immco Diagnostics, Inc.. Device class: 2.
Clearance details
- Applicant
- Immco Diagnostics, Inc.
- Product code
- Code LKO
- Device class
- Class 2
- Regulation
- 21 CFR 866.5100
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Buffalo, NY, US
Recent devices under product code LKO
view all- K191085 — Maverick RNP Assay and Maverick Diagnostic System
- K140224 — EUROIMMUN EUROLINE ENA PROFILE 9AG (IGG)
- K123261 — EUROIMMUN ANTI-NRNP/SM ELISA (IGG)
- K083117 — ELIA RNP70 IMMUNOASSAY, ELIA SCI-70 IMMUNOASSAY AND ELIA JO-1 IMMUNOASSAY, MODELS 14-5511-01, 14-5506-01 AND 14-5507-01
- K071210 — MODIFICATION TO FIDIS CONNECTIVE 10*, MODEL MX006
More clearances from Immco Diagnostics, Inc.
view all- K172745 — ImmuGlo HEp-2 Elite IFA
- K172078 — ImmuLisa Enhanced RNA POL III Antibody ELISA
- K163133 — ImmuLisa Enhanced AMA IgG Antibody ELISA; ImmuLisa Enhanced AMA IgA/IgG/IgM Antibody ELISA
- K163177 — ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISA
- K162788 — ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA
Data sourced from openFDA. This site is unofficial and independent of the FDA.